Saltar al contenido
Merck
Todas las fotos(1)

Documentos

217042

Sigma-Aldrich

4,4,4-Trifluoro-1-phenyl-1,3-butanedione

99%

Sinónimos:

BTA

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Fórmula lineal:
C6H5COCH2COCF3
Número de CAS:
326-06-7
Peso molecular:
216.16
EC Number:
206-307-8
MDL number:
MFCD00000425
UNSPSC Code:
12352100
PubChem Substance ID:
24852988
NACRES:
NA.22

assay

99%

form

solid

bp

224 °C (lit.)

mp

38-40 °C (lit.)

solubility

95% ethanol: soluble 25 mg/mL, clear, colorless to yellow

SMILES string

FC(F)(F)C(=O)CC(=O)c1ccccc1

InChI

1S/C10H7F3O2/c11-10(12,13)9(15)6-8(14)7-4-2-1-3-5-7/h1-5H,6H2

InChI key

VVXLFFIFNVKFBD-UHFFFAOYSA-N

Application

4,4,4-Trifluoro-1-phenyl-1,3-butanedione was used in the synthesis of series of NNO ketoimines bearing trifluoromethyl substituents via Schiff base condensation reaction. It was also used in mixed-ligand chelate extraction of trivalent lanthanides and as a ligand in the preparation of ternary lanthanide (Ln) complexes.

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

210.2 °F - closed cup

flash_point_c

99 °C - closed cup

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Los clientes también vieron

Slide 1 of 2

1 of 2

Hexafluoroacetylacetone 98%

Sigma-Aldrich

238309

Hexafluoroacetylacetone

1,3-Diphenyl-1,3-propanedione 98%

Sigma-Aldrich

D33454

1,3-Diphenyl-1,3-propanedione

Makoto Utsunomiya et al.
JACC. Cardiovascular interventions, 10(2), 188-194 (2017-01-21)
This study aimed to assess the optimal angiographic endpoint of endovascular therapy (EVT) for wound healing. Several reports have demonstrated acceptable patency and limb salvage rates following infrapopliteal interventions for the treatment of critical limb ischemia (CLI). However, the optimal angiographic
Syntheses, crystal structures, visible and near-IR luminescent properties of ternary lanthanide (Dy3+, Tm3+) complexes containing 4, 4, 4-trifluoro-1-phenyl-1, 3-butanedione and 1, 10-phenanthroline.
Feng J, et al.
Journal of Luminescence, 128(12), 1957-1964 (2008)
Meixia Shan et al.
Science advances, 4(9), eaau1698-eaau1698 (2018-09-27)
The development of new membranes with high H2 separation performance under industrially relevant conditions (high temperatures and pressures) is of primary importance. For instance, these membranes may facilitate the implementation of energy-efficient precombustion CO2 capture or reduce energy intensity in
Jean-Jacques Body et al.
Journal of bone oncology, 14, 100212-100212 (2019-01-11)
Bone metastases (BMs) are common in patients with prostate cancer and can lead to skeletal-related events (SREs), which are associated with increased pain and reduced quality of life (QoL). Bone-targeted agents (BTAs), such as zoledronic acid and denosumab, reduce the
M E Grobman et al.
Journal of veterinary internal medicine, 33(3), 1423-1433 (2019-04-11)
Megaesophagus (ME) carries a poor long-term prognosis in dogs. In people, lower esophageal sphincter (LES) achalasia is a rare cause of ME that may respond to targeted intervention. Dogs with lower esophageal sphincter achalasia-like syndrome (LES-AS) have been described recently
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico